A Comparitive Study Of Bupivacaine 0.5% And Ropivacaine 0.5% For Ultrasound Guided Supraclavicular Brachialplexus Block
H S Prajwal Patel*, Sarvesh B, B T Shivaramu
Associate Professor, Department of Anaesthesia, Adichunchanagiri Institute of Medical Sciences, Mandya, Karnataka, India.
*Corresponding Author
H S Prajwal Patel,
Associate Professor, Department of Anaesthesia, Adichunchanagiri Institute of Medical Sciences, Mandya, Karnataka, India.
E-mail: prajwal.patel83@gmail.com
Received: February 26, 2021; Accepted: October 11, 2021; Published: October 12, 2021
Citation: H S Prajwal Patel, Sarvesh B, B T Shivaramu. A Comparitive Study Of Bupivacaine 0.5% And Ropivacaine 0.5% For Ultrasound Guided Supraclavicular Brachialplexus Block. Int J Anesth Res. 2021;09(03):642-646. doi: dx.doi.org/10.19070/2332-2780-21000127
Copyright: H S Prajwal Patel© 2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Supraclavicular Brachial plexus block provides safe, effective, low cost anaesthesia with excellent post operativeanalgesia.
With the advent of ultrasound guidance establishing the blockade has been easier with reduced drug dosage and
less complications.
Objective: To compare the effect of bupivacaine 0.5% &ropivacaine 0.5% used for ultrasound guided supraclavicular brachial
plexus block with respect to onset and duration of sensory blockade, onset and duration of motor blockade, duration of
analgesia.
Methods: 60 patients of ASA class 1 and 2 for upper limb surgical procedures were randomly allocated into two groups of 30
each, Group B – i.e Bupivacaine group receives 20 ml Bupivacaine 0.5% ( 5 mg/ml), Group R – i.e Ropivacaine group receives
20 ml Ropivacaine 0.5% ( 5 mg/ml ).With ultrasound guidance supraclavicular brachialplexus block was administered. Testing
for onset of sensory blockade was done using pin prick method,motor block was assessed using modified bromage scale, post
operatively patients would be assessed for the duration of sensory and motor blockade.
Results: The present study shows that the onset of sensory,motor blocks was significantly earlier in bupivacaine 0.5% group
(Group B) in comparision with ropivacaine0.5% group (Group R ).The duration of motor, sensory block and duration of
analgesia was longer in Bupivacaine0.5% group compared with Ropivacaine0.5% group.
Conclusion: Bupivacaine 0.5 % has early onset of sensory blockade ,early onset of motor blockade,prolonged duration of
sensory blockade, motor blockade, prolonged duration of analgesia when compared to ropivacaine 0.5 % at equal volumes
when used for supraclavicular brachial plexus block under ultrasound guidance without any adverse effects.
2.Introduction
3.Methodology
4.Results
5.Discussions
6.Conclusion
7.Acknowledgments
8.References
Keywords
Bupivacaine; Ropivacaine; Ultrasound; Supraclavicular Brachialplexus Block.
Introduction
Peripheral nerve blocks have become important in clinical practice
because of their role in post operative pain relief, shortening
of patient recovery time & avoiding risks and adverse effects of
general anaesthesia [1]. Brachial plexus block at the supraclavicular
level provides anaesthesia for the upper limb surgeries by
blocking the middle & lower plexus (Median, Radial and Ulnar
N).
The use of ultrasound has gained popularity in the field of regional
anaesthesia, as it has many advantages over the conventional
technique of nerve stimulation. It provides a direct visualization
of the anatomic structures and helps in minimizing vascular
punctures by allowing a dynamic vision of the needle advancement
and local anaesthetic spread.
Ultrasound guided supraclavicular brachial plexus block has become
popular currently, owing to detection of anatomical variation
of brachial plexus, accuracy of needle placements and
avoidance of needle related complications such as injury to blood
vessels, pneumothorax & local anesthetictoxicity [2].
Bupivacaine is a long acting local anaesthetic. Due to its long duration
of action and combined with its high quality sensory blockade
compared to motor blockade it has been the most commonly
used local anaesthetic for peripheral nerve blocks.
Ropivacaine is a newer, long acting local anaesthetic whose neuronal
blocking potential used in peripheral nerve blockade seems to be equal or superior to bupivacaine. Studies shows that it has
significantly greater safety margin over bupivacaine because of
lower CNS and cardiac toxicity and hence can be used in higher
concentrations. One of the drawbacks of ropivacaine mentioned
is its less intense motor blockade compared to bupivacaine [3].
Hence here is an attempt was made through the study to compare
bupivacaine 0.5% with ropivacaine0.5% in supraclavicular brachial
plexus block under ultrasound guidance.
Materials And Methods
A prospective randomized study is planned.60 patients of ASA I
and II physical status aged 18-55yrs will be scheduled to undergo
elective upper limb surgical procedures. They will be randomly
allocated into two groups by computer generated randomization
into
Group B – i.e Bupivacaine group receives 20 ml Bupivacaine
0.5% (5 mg/ml)
Group R – i.e Ropivacaine group receives 20 ml Ropivacaine
0.5% (5 mg/ml)
Inclusion criteria:
a) Age group between 18-45 yrs
b) ASA I and II
c) Patients with body weight of 50-80kgs
d) Who gives informed written consent
Exclusion criteria:
a) Patients not willing to give informed consent
b) Unco-operative patients
c) Local pathology at the site of injection
d) History of bleeding disorders, convulsions, severe neurological
deficit and allergy
e) History of major organ system illness (cardiac, respiratory, hepatic
and renal failure)
Methodology
After obtaining approval and clearance from the institutional ethical
committee, the patients fulfilling the inclusion criteria will be
enrolled for the study after obtaining informed consent.
Patients admitted for upper limb surgical procedures will be taken
up for the study.
All the patients will undergo pre anaesthetic evaluation and routine
necessary investigations will be carried out. Patients coming
under ASA I and II category would be explained about the procedure
in detail.
A total of 60 no of patients will be randomly allocated into two
groups of 30 each
Group B – i.e Bupivacaine group receives 20 ml Bupivacaine
0.5% (5 mg/ml)
Group R – i.eRopivacaine group receives 20 ml Ropivacaine 0.5%
(5 mg/ml)
All the patients will be prescribed 0.5mg of alprazolam and
150mg of ranitidine orally to be taken on the night before surgery.
Patients will also be advised to be nil orally from 10pm onward on
the night before surgery.
Ensuring overnight NPO status, on arrival in the OT, patient will
be placed in supine position on OT table and monitors will be
connected HR, NIBP, ECG and SPO2 will be recorded as per
standard ASA guidelines. Premedication which includes injection
midazolam 0.04mg/kg iv would be administered after obtaining
an IV access with 18G catheter. Under strict aseptic precautions
supraclavicular brachial plexus block performed by ultrasound
guided approach in plane technique.After real time visualization
of brachial plexus by ultrasound, needle was placed near the
plexus, following negative aspiration of blood, drug solution was
injected around the brachial plexus.
Testing for onset of sensory blockade will be done using pin prick
method, the assessment will be made every 1 minute thereafter till
patients feels no pain to pinprick. Motor block will be assessed using
modified Bromage scale. After the surgical procedure patients
would be assessed for the duration of sensory and motor blockade
and the time noted. Assessment of sensory blockade will be
on VAS scale. Cessation of analgesia is taken at the time when the
patient asks for rescue analgesia. Any untoward effects during the
procedure will be noted down.
Scoring Systems
Sensory block
The sensory block will be assessed by pin prick with 25 gauge
needle.
Sensory Block
0. Sharp pain
1. Touch sensation only
2. Not even touch sensation
Pain rating scale
Visual analouge scale
A simple assessment tool consisting of a 10 cm line with 0 on one
end, representing no pain, and 10 on the other, representing the
worst pain over ever experienced, with a patient marks to indicate
the severity of his or her pain.
Motor block
Modified Bromage scale
0 - Able to raise the extended arm to 90º for a full 2 secs.
1 - Able to flex the elbow and move the fingers but unable to raise
the extended arm.
2 - Unable to flex the elbow but able to move the fingers.
3 - Unable to move the arm, elbow or fingers.
Onset of motor blockade will be considered when there will be
Grade 1 motor blockade. Peak motor block will be considered
when there will be Grade 3 motor blockade.
Statistical Analysis
Statistical analysis of data will be done using student t test (z test)
for parametric data. Non parametric data will be analyzed by Chisqure
test. Statistical significance was considered if P value < 0.05.
Results And Observation
No statistical significance was found in demographic profile of
age, sex and weight, thereby making the two groups similar and
comparable.
In Group B , the mean onset time of sensory blockade and motor
blockade was 17.70 ± 2.35 min and 25.43 ± 2.22 min Respectively
when compared to Group R havingonset time of sensory blockade
and Motor blockade of 22.13 ± 3.05min and 27.90 ± 1.88
min Respectively. Onset time of Sensory and Motor blockade was
earlier in Group B when compared with Group R .The p value
was < 0.001 which is statistically highly significant.
In Group B , the Mean Duration of Sensory blockade and Motor
blockade was 342.00 ± 47.66 min and 369.00 ± 41.05 min
Respectively when compared to Group R having Mean Duration
of sensory blockade and Motor blockade of 302.00 ± 42.38 min
and 336.00 ± 37.29 min Respectively .
Duration of Sensory and Motor blockade was prolonged in
Group B when compared with Group R . The p value was 0.001
and 0.001 respectively which is statistically highly significant.
In Group B , the mean duration of analgesia was 372.00 ± 42.86
min when compared to Group R having mean duration of analgesia
of 341.00 ± 36.52 min. Duration of analgesia was prolonged
in Group B when compared with Group R .The p value was 0.004
which is statistically highly significant.
Haemodynamic Parameters
Intra operative and post block haemodynamic parameters like
heart rate, systolic blood pressure, diastolic blood pressure, mean
arterial pressure, peripheral oxygen saturation in percentage
(SpO2) were normal in both the groups requiring no intervention
and the differences between the two groups were statistically
insignificant.
Discussions
This section is devoted for the discussion of the results of the
present clinical study entitled “a comparitive study of bupivacaine
0.5% andropivacaine 0.5% for ultrasound guided supraclavicular
brachialplexus block”conducted to compare the effects of bupivacaine
0.5% 20ml andropivacaine 0.5% 20ml on the block characteristics,
based on its objectives. After obtaining ethical committee
clearance and written informed consent, 60 ASA status I
and II patients, undergoing elective upper limb surgeries under
ultrasound guided supraclavicular brachial plexus block, were randomly
divided into two groups Group B and Group R (30 each)
to receive bupivacaine 0.5% 20ml and ropivacaine 0.5% 20ml respectively.
All patients were administered ultrasound guided supraclavicular
brachial plexus block under aseptic precautions using
the study drugs and the various parameters were studied.
In the present study ultrasound guided technique was chosen for
administering supraclavicular brachial plexus block as it offers many advantages over the conventional technique of nerve stimulation
and paraesthesia like, providing a direct visualization of the
anatomical structures, dynamic vision of the needle advancement
and local anaesthetic spread around the nerve roots. It has also
been shown to reduce the number of needle passes or redirections
needed to perform the block, provide enhanced sensory and
motor blocks, allow shorter procedure times with fewer vascular
punctures, it may also reduce the incidence of major block complications,
as compared to the nerve stimulation technique.
The most commonly used local anaesthetics for peripheral nerve
blocks are Lignocaine and Bupivacaine. The local anaestheticRopivacaine
was chosen for the current study as it is a newer, long acting
amide local anaesthetic with similar clinical properties, efficacy
and duration of post-operative pain relief as that of the conventionally
used bupivacaine, with the added advantage of being less
lipophilic then bupivacaine, which accounts for its decreased central
nervous system toxicity and cardiotoxicity, as proven by many
authors like Usha badole et al., Ajai Vikram Singh et al., Veena
Chatrath et al [4, 5].
A volume of 20ml of 0.5% of ropivacaine was used by Ushaet
al. where they have used ultrasound for giving the block. So
from above studies it was concluded that the volume of 0.5%
ropivacaine and 0.5% bupivacaine required for ultrasound guided
supraclavicular brachial plexus block was 20 ml. So the local anaesthetic
volume of 20 ml of 0.5% ropivacaine and 0.5% bupivacaine
was chosen in the present study.
Sensory Block
Time of onset of sensory
In our study, we observed that onset time of sensory block was
earlier in Bupivacaine group (Group B) having a mean value of
17.70 ± 2.35 minutes in comparision with Ropivacaine group
(Group R) having a mean value of 22.13 ± 3.05 minutes. The difference
between the two groups in terms of sensory block onset
was statistically significant. p value <0.001.
These results were comparable with those obtained in the studies
conducted by K Shaw, D Tripathi et al, Singelyn FJ et al [6, 7].
Conclusion
From the present study it can be concluded that Bupivacaine 0.5 % has early onset of sensory blockade ,early onset of motor
blockade, prolonged duration of motor blockade, prolonged duration
of analgesia when compared to Ropivacaine 0.5 % at equal
volumes. Both the drugs maintain stable hemodynamic profile
perioperatively and are devoid of any side effects at the concentration
and volumes used for the study.
References
- Partridge BL, Katz J, Benirschke K. Functional anatomy of the brachial plexus sheath: implications for anesthesia. Anesthesiology. 1987 Jun;66(6):743- 7. PubmedPMID: 3592273.
- Kessler J, Gray AT. Ultrasound guidance for regional anaesthesia. In:Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL, editors. Miller’s anaesthesia. 8th Ed. Philadelphia: Elsevier Saunders. 2015:1752-66.
- Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. The Journal of the American Society of Anesthesiologists. 1991 Apr 1;74(4):639-42.
- Ushabadole, Akshaysalunke. a comparative study of bupivacaine 0.5% and ropivacaine 0.5% in ultrasound guided axillary block. Global journal for research analysis. 2017:6(10):42-4.
- Chatrath V, Sharan R, Kheterpal R, Kaur G, Ahuja J, Attri JP. Comparative evaluation of 0.75% ropivacaine with clonidine and 0.5% bupivacaine with clonidine in infraclavicular brachial plexus block. Anesth Essays Res. 2015 May-Aug;9(2):189-94. PubmedPMID: 26417126.
- Tripathi D, Shah K, Shah C, Shah S, Das E. Supraclavicalar brachial plexus block for upper limb orthopedic surgery: A randomized, double blinded comparison between ropivacaine and bupivacaine. The Internet Journal of Anesthesiology. 2012 Nov;30(4).
- Singelyn FJ. Clinical application of ropivacaine for the upper extremity. Curr Top Med Chem. 2001 Aug;1(3):219-25. PubmedPMID: 11895140.
- McGlade DP, Kalpokas MV, Mooney PH, Chamley D. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesthesia and intensive care. 1998 Oct 1;26(5):515.
- Hickey R, Rowley CL, Candido KD, Hoffman J, Ramamurthy S, Winnie AP. A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block. Anesthesia and analgesia. 1992 Oct 1;75(4):602-6.
- Vaghadiah, chan v, Ganapathy S et alA Multicentric trial of Ropivacaine7.5mg/ml vs bupivacaine 5 mg/ml for supraclavicular brachial plexusAnesthesia . Canadian Journal of Anesthesia ,1999;46-10: pp 946-951.
- Syed Ali Aasim, A.Srikanth Reddy, Anil Kumer, KarthikSatya S. Prospective study of the efficacy of clonidine added to ropivacaine as compared with ropivacaine alone in supraclavicular brachial plexus block. Ann.Int.Med. Den.Res. 2017;3(4):1-4.
- Gupta K, Tiwari V, Gupta PK, Pandey MN, Singhal AB, Shubham G. Clonidine as an adjuvant for ultrasound guided supraclavicular brachial plexus block for upper extremity surgeries under tourniquet: A clinical study. J AnaesthesiolClinPharmacol. 2014 Oct;30(4):533-7. PubmedPMID: 25425780.
- Lew E, Vloka JD, Hadžić A. Ropivacaine for peripheral nerve blocks: Are there advantages?. Techniques in Regional Anesthesia and Pain Management. 2001 Apr 1;5(2):56-9.